Duramorph PF injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Duramorph PF injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Duramorph PF, Infumorph, Mitigo, Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, RMS, Roxanol
Synonyms: Duramorph PF (injection)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Duramorph PF injection-Insulin degludec
- Duramorph PF injection-Insulin Degludec (U-100) Prefilled Pens
- Duramorph PF injection-Insulin Degludec (U-100) Vials
- Duramorph PF injection-Insulin Degludec (U-200) Prefilled Pens
- Duramorph PF injection-Insulin degludec and liraglutide
- Duramorph PF injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Durapren Injection
- Insulin aspart, recombinant Subcutaneous-DuraProxin ES
- Insulin aspart, recombinant Subcutaneous-Durasal
- Insulin aspart, recombinant Subcutaneous-Durasal Topical
- Insulin aspart, recombinant Subcutaneous-DuraTan DM
- Insulin aspart, recombinant Subcutaneous-Duration